Clinical Trial

Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes

Study acronym: ANODE04
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
A single-site, open label, confirmatory study assessing two biomarkers indicative of levels of glycaemia; glycated keratin in fingernails and glycated haemoglobin (HbA1c). Screening for diabetes
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-06-17; most recent amendment 2026-03-26.
Status change: Recruiting → Active, Not Recruiting 2026-03-26
Status change: Not Yet Recruiting → Recruiting 2026-02-10
Trial Details
NCT Number NCT07039357
Lead Sponsor Glyconics Ltd
Collaborators: Queen Mary University of London
Conditions Diabetes Mellitus, Healthy
Enrollment 100 participants
Start Date 2026-01-28
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-27